Article ID Journal Published Year Pages File Type
8226300 International Journal of Radiation Oncology*Biology*Physics 2012 8 Pages PDF
Abstract
Pretreatment risk factors (clinical tumor stage, Gleason score, pretreatment PSA) strongly predict for patients achieving nPSA <0.5 ng/mL following brachytherapy, and this cohort had significantly higher long-term FFBF.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
PSA Nadir of <0.5 ng/mL Following Brachytherapy for Early-Stage Prostate Adenocarcinoma is Associated With Freedom From Prostate-Specific Antigen Failure
Authors
, , , ,